Myozyme, Poudre pour solution à diluer pour perfusion - 25 Durchstechflasche(n) Swissmedic Key 58038002 Registration Holder Sanofi-Aventis (Suisse) SA Name Myozyme, Poudre pour solution à diluer pour perfusion Date of registration 22.05.2008 Introduction of Sequence 22.05.2008 ATC-Classification Alglucosidase Alfa (A16AB07) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 07.14. Show package size 25 Durchstechflasche(n) Index Therapeuticus (Swissmedic) 07.14. Description Swissmedic categorie. A SL Eintrag No Indication Information for professionals IP Consumer information Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680580380025 Medication Code Biotechnologika Pharmacode Disponibility
Composition Praeparatio cryodesiccata: alglucosidasum alfa 50 mg, mannitolum, polysorbatum 80, dinatrii phosphas heptahydricus, natrii dihydrogenophosphas monohydricus, pro vitro, natrium 6.56 mg. Packungsbestandteile correspond alglucosidasum alfa 5 mg/ml BAG: Active Agent Dose Alglucosidasum Alfa 50 mg
Label Praeparatio cryodesiccata:
Galenic Form Poudre pour solution à diluer pour perfusion Excipiens Active Agent Dose Alglucosidasum Alfa 50 mg
BAG: Active Agent Dose Alglucosidasum Alfa 50 mg
Inactive agents Disodium Phosphate Heptahydrate Mannitol Sodium Dihydrogenophosphate Monohydrate Polysorbatum 80
Source Data was imported : 06.11.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
